BRCA2 and metastatic malignant neoplasm in the lymph nodes: We found that most of the mutations carried by patients with an onset age of ≤ 45 years were located in the region of exon 15 or behind exon 15, and 80.0% of the patients with BRCA2 possible disease-causing mutations had lymph node metastases.